Explanation
immune-modulationtherapy
Lvmphomasecondar
variousstudieshaveatemotedtoestimatethelona-termriskofvmphomaafftertreatment with antitumour
necrosisfactor-alpha(TNF-qjimmune-moculationtheraov(infuiximab).TheFoodandDruqAdministration
(FDAestimateatwotosix-foldincreasedriskofvmohoma.andantiTNF-q aqentscarryawarninqlabeu
concerningtheriskofmalignancy.
@1MINENDOCRINE
